Briefs: Ami Organics and Panacea Biotec
News

Briefs: Ami Organics and Panacea Biotec

Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan

  • By IPP Bureau | April 25, 2025

Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan

Ami Organics Limited's manufacturing facility, Unit II situated at Ankleshwar, which is involved in manufacturing of various intermediates for Active Pharmaceuticals Ingredients, has on today received Good Manufacturing Practices (GMP) by Pharmaceutical and Medical Devices Agency, Japan (PMDA).

Panacea Biotec receives additional award from UNICEF for supply of bOPV

Panacea Biotec Limited has received an additional Award from UNICEF for supply of 40 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 5.20 million (~Rs.44 crore) in Q3 CY2025. The company had earlier received Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 14.95 million (~Rs.127 crore) in CY2025.

Upcoming E-conference

Other Related stories

Startup

Digitization